Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

INTRODUCTION: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients with advanced non-small cell lung cancer (NSCLC). PD-L1 testing has been validated and is currently certified only on formalin-fixed paraffin-em...

詳細記述

保存先:
書誌詳細
出版年:Ther Adv Med Oncol
主要な著者: Ricci, Costantino, Capizzi, Elisa, Giunchi, Francesca, Casolari, Laura, Gelsomino, Francesco, Rihawi, Karim, Natali, Filippo, Livi, Vanina, Trisolini, Rocco, Fiorentino, Michelangelo, Ardizzoni, Andrea
フォーマット: Artigo
言語:Inglês
出版事項: SAGE Publications 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7711224/
https://ncbi.nlm.nih.gov/pubmed/33299472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920954802
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料